Nam Hoon Kim Selected Research

Nam Hoon Kim Research Topics

Disease

21	Type 2 Diabetes Mellitus (MODY) 01/2022 - 05/2017
7	Cardiovascular Diseases (Cardiovascular Disease) 09/2022 - 01/2018
6	Infections 05/2022 - 05/2005
6	Non-alcoholic Fatty Liver Disease 07/2021 - 04/2014
5	Chronic Kidney Failure (Chronic Renal Failure) 12/2021 - 01/2019
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 07/2013
5	Diabetes Mellitus 07/2021 - 01/2017
4	Myocardial Infarction 09/2022 - 01/2018
4	COVID-19 05/2022 - 01/2021
4	Ischemic Stroke 01/2022 - 01/2018
4	Insulin Resistance 11/2021 - 09/2018
4	Diabetes Complications 01/2021 - 12/2018
4	Stroke (Strokes) 01/2020 - 11/2017
4	Inflammation (Inflammations) 01/2020 - 05/2005
3	Dementia (Dementias) 11/2022 - 11/2017
3	Dyslipidemias (Dyslipidemia) 11/2022 - 12/2021
3	Albuminuria 01/2021 - 01/2019
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2007 - 09/2003
2	Body Weight (Weight, Body) 01/2022 - 09/2018
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022 - 11/2019
2	Hypertension (High Blood Pressure) 12/2021 - 01/2021
2	Thyroid Neoplasms (Thyroid Cancer) 10/2020 - 10/2016
2	Heart Failure 01/2020 - 11/2019
2	Hypothyroidism 05/2019 - 10/2016
2	Atherosclerosis 01/2019 - 07/2013
2	Atrial Fibrillation 01/2019 - 11/2004
2	Neoplasms (Cancer) 11/2018 - 09/2005
2	Renal Insufficiency (Renal Failure) 01/2018 - 12/2006
2	Hepatocellular Carcinoma (Hepatoma) 10/2014 - 05/2005
2	Chronic Hepatitis B 09/2009 - 06/2004
1	Osteoporosis 09/2022
1	Thyroid Diseases (Thyroid Disease) 09/2022
1	Severe Fever with Thrombocytopenia Syndrome 07/2022
1	Communicable Diseases (Infectious Diseases) 07/2022
1	Peripheral Arterial Disease 01/2022
1	Drug-Related Side Effects and Adverse Reactions 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Uveal melanoma 12/2021
1	Eye Neoplasms (Eye Cancer) 12/2021
1	Gestational Diabetes (Gestational Diabetes Mellitus) 10/2021
1	Osteoporotic Fractures 09/2021
1	Hyperthyroidism 01/2021

Drug/Important Bio-Agent (IBA)

14	Glucose (Dextrose)FDA LinkGeneric 11/2022 - 12/2009
5	Indicators and Reagents (Reagents)IBA 12/2021 - 11/2017
5	Triglycerides (Triacylglycerol)IBA 11/2021 - 04/2014
4	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2022 - 05/2017
4	Pharmaceutical PreparationsIBA 01/2022 - 01/2018
4	Metformin (Glucophage)FDA LinkGeneric 12/2021 - 06/2017
4	Biomarkers (Surrogate Marker)IBA 11/2021 - 07/2013
4	CholesterolIBA 01/2021 - 01/2019
4	Hypoglycemic Agents (Hypoglycemics)IBA 10/2019 - 05/2017
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2019
3	Insulin (Novolin)FDA Link 12/2021 - 05/2017
3	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2007
3	Sodium-Glucose Transport ProteinsIBA 01/2021 - 01/2018
3	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2021 - 06/2017
3	C-Reactive ProteinIBA 10/2018 - 06/2017
2	CalciumIBA 09/2022 - 12/2009
2	Vitamin D FDA LinkGeneric 09/2022 - 11/2015
2	IodineIBA 09/2022 - 10/2020
2	VaccinesIBA 07/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 05/2022 - 05/2005
2	Antiviral Agents (Antivirals)IBA 01/2021 - 09/2009
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2021 - 10/2019
2	TransferasesIBA 01/2020 - 01/2020
2	Thyroxine (Levothyroxine)FDA LinkGeneric 05/2019 - 10/2016
2	SteroidsIBA 05/2019 - 11/2007
2	CreatinineIBA 10/2018 - 12/2006
2	Alanine Transaminase (SGPT)IBA 10/2018 - 01/2018
2	EnzymesIBA 02/2018 - 01/2018
2	alpha-Fetoproteins (alpha-Fetoprotein)IBA 09/2005 - 05/2005
2	CopperIBA 08/2004 - 09/2003
1	Blood Glucose (Blood Sugar)IBA 09/2022
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 09/2022
1	Peptides (Polypeptides)IBA 07/2022
1	AntibodiesIBA 05/2022
1	Neutralizing AntibodiesIBA 05/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	empagliflozinIBA 01/2022
1	LDL CholesterolIBA 01/2022
1	oxidized low density lipoproteinIBA 01/2022
1	GlucosidasesIBA 12/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 12/2021
1	Type C PhospholipasesIBA 12/2021
1	sarcoma-associated antigen S1IBA 01/2021
1	AntigensIBA 01/2021
1	Hemoglobins (Hemoglobin)IBA 01/2020
1	Interleukin-15 (Interleukin 15)IBA 01/2020

Therapy/Procedure

10	Therapeutics 07/2022 - 11/2004
3	Glycemic Control 01/2021 - 08/2017
2	Gastrectomy 01/2022 - 05/2006
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 11/2019
2	Aftercare (After-Treatment) 06/2017 - 11/2007
2	Enema (Enemas) 12/2009 - 02/2006
1	Duration of Therapy 01/2022
1	Fitness Trackers 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Continuous Renal Replacement Therapy 01/2021
1	Extracorporeal Membrane Oxygenation 01/2021